LENZ Therapeutics, Inc.LENZNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank83
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-5.61
↑ 99% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
-959.04
Historical baseline
PeriodValueYoY Change
2025-5.61+54.5%
2024-12.34-755.2%
2023-1.44+87.3%
2022-11.39-65.3%
2021-6.89+35.2%
2020-10.63+99.8%
2019-6665.00-